| 注册
首页|期刊导航|国际医药卫生导报|膈下逐瘀汤加减治疗对气滞血瘀型肝癌患者的有效性及肝功能指标的影响

膈下逐瘀汤加减治疗对气滞血瘀型肝癌患者的有效性及肝功能指标的影响

荆进红 强春倩

国际医药卫生导报2020,Vol.26Issue(4):539-542,4.
国际医药卫生导报2020,Vol.26Issue(4):539-542,4.DOI:10.3760/cma.j.issn.1007-1245.2020.04.030

膈下逐瘀汤加减治疗对气滞血瘀型肝癌患者的有效性及肝功能指标的影响

Effect of Gexia Zhuyu Decoction for patients with qi stagnation and blood stasis liver cancer and its influence on liver function

荆进红 1强春倩1

作者信息

  • 1. 烟台市奇山医院 264000
  • 折叠

摘要

Abstract

Objective To investigate the effect of Gexia Zhuyu Decoction for patients with qi stagnation and blood stasis liver cancer and its influence on liver function.Methods A total of 100 patients with qi stagnation and blood stasis liver cancer treated at our hospital from May,2014 to May,2019 were randomly divided into a control group and a study group,with 50 patients in each group.The control group was treated with given FOLFOX4 systemic chemotherapy,and the study group with Gexia Zhuyu Decoction.The total clinical effective rates and levels ofALT,TBIL,HA,LN,and PCⅢ were compared between these two groups.Results The total effective rate was higher in the study group than in the control group [92.0% (46/50) vs.64.0% (32/50);P < 0.05].After the treatment,the levels of AFP,ALT,TBIL HA,LN,and PCⅢ were lower in the observation group than in the control group [(401.5±102.1) μg/L vs.(678.7±129.6) μg/L,(41.1±13.7) U/L vs.(83.2±21.9) U/L,(9.1±2.2)μmol/L vs.(19.4±5.3) μmol/L,(168.2±12.7) μg/L vs.(301.7±14.5) μg/L,(158.7±14.8) μg/L vs.(351.2±29.9) μg/L,and (11.3±3.7) μmol/L vs.(22.5±6.2) μmol/L;all P < 0.05].Conclusion Gexia Zhuyu Decoction for patients with qi stagnation and blood stasis liver cancer is effective,and can effectively improve their liver function and reduce their symptoms of liver fibrosis,so it is worth being clinically generalized.

关键词

膈下逐瘀汤/加减治疗/气滞血瘀型/肝癌/肝功能指标

Key words

Gexia Zhuyu Decoction/Plus or minus treatment/Qi stagnation and blood stasis type/Liver cancer/Liver function indicators

引用本文复制引用

荆进红,强春倩..膈下逐瘀汤加减治疗对气滞血瘀型肝癌患者的有效性及肝功能指标的影响[J].国际医药卫生导报,2020,26(4):539-542,4.

国际医药卫生导报

1007-1245

访问量3
|
下载量0
段落导航相关论文